- Previous Close
250.05 - Open
258.90 - Bid 250.05 x --
- Ask 257.00 x --
- Day's Range
250.05 - 258.90 - 52 Week Range
220.10 - 396.95 - Volume
1,530 - Avg. Volume
11,979 - Market Cap (intraday)
2.925B - Beta (5Y Monthly) -0.69
- PE Ratio (TTM)
46.10 - EPS (TTM)
5.43 - Earnings Date May 12, 2025 - May 16, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Sanjivani Paranteral Limited operates as a pharmaceutical company in India. It manufactures pharmaceutical products in a form of oral solids, small volume parenteral, and sterile powder formulations for various therapeutic areas comprising central nervous system, cardiovascular system, antibiotics, gastroenterological, anti-diabetics, and anti-allergic. It also offers soft gels, topicals, nasal sprays, liquid injection, capsules, tablets, dry syrups, and ear/eye drops. The company also exports its products. Sanjivani Paranteral Limited was incorporated in 1994 and is headquartered in Mumbai, India.
www.sanjivani.co.in33
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: SANJIVIN.BO
View MorePerformance Overview: SANJIVIN.BO
Trailing total returns as of 4/16/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SANJIVIN.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SANJIVIN.BO
View MoreValuation Measures
Market Cap
2.92B
Enterprise Value
2.82B
Trailing P/E
46.05
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.05
Price/Book (mrq)
9.16
Enterprise Value/Revenue
4.40
Enterprise Value/EBITDA
26.60
Financial Highlights
Profitability and Income Statement
Profit Margin
11.06%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
647.81M
Net Income Avi to Common (ttm)
71.66M
Diluted EPS (ttm)
5.43
Balance Sheet and Cash Flow
Total Cash (mrq)
51.97M
Total Debt/Equity (mrq)
22.60%
Levered Free Cash Flow (ttm)
--